Literature DB >> 4077961

Typing of Pseudomonas cepacia by bacteriocin susceptibility and production.

J R Govan, G Harris.   

Abstract

The significance of Pseudomonas cepacia as an opportunistic pathogen in immunocompromised patients has become increasingly recognized. Particularly disturbing is its increased incidence, reported by several North American centers, in respiratory tract cultures from patients with cystic fibrosis. Epidemiological studies of P. cepacia have been hampered by a lack of typing methods. In this paper we report the development of a typing scheme based on bacteriocin production and susceptibility. For bacteriocin production, test isolates of P. cepacia were rapidly applied to the surfaces of agar plates with a multiple inoculator. After incubation of these test isolates for 5.5 h and their exposure to chloroform, indicator strains were applied in agar overlays without prior removal of the test strain growth. After 18 h of incubation, inhibition zones caused by bacteriocin activity were recognized. A similar procedure was used to examine the bacteriocin susceptibility of the test strain. The bacteriocin type of the test strain was defined based on its bacteriocin production as judged by zones of inhibition against a set of eight indicator strains and by susceptibility or resistance of the test strain to bacteriocin produced by six producer strains. Of 373 strains of P. cepacia, 95.2% were typed into a total of 44 type combinations. Bacteriocin typing provided a suitable procedure for epidemiological studies of colonization or infection by P. cepacia. The technique described in this paper was simple to perform, gave a result within 24 h, provided good strain discrimination, and was suitable for clinical, environmental, and phytopathogenic strains.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4077961      PMCID: PMC268451          DOI: 10.1128/jcm.22.4.490-494.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Aqueous quaternary ammonium antiseptics and disinfectants. Use and misuse.

Authors:  R E Dixon; R A Kaslow; D C Mackel; C C Fulkerson; G F Mallison
Journal:  JAMA       Date:  1976-11-22       Impact factor: 56.272

2.  Two modes of loss of the Tol function from Pseudomonas putida mt-2.

Authors:  S A Bayley; C J Duggleby; M J Worsey; P A Williams; K G Hardy; P Broda
Journal:  Mol Gen Genet       Date:  1977-07-20

3.  Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source.

Authors:  W Beckman; T G Lessie
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

4.  Pseudomonas cepacia as contaminant and infective agent.

Authors:  L J Pallent; W B Hugo; D J Grant; A Davies
Journal:  J Hosp Infect       Date:  1983-03       Impact factor: 3.926

5.  Studies on the pyocins of Pseudomonas aeruginosa: production of contractile and flexuous pyocins in Pseudomonas aeruginosa.

Authors:  J R Govan
Journal:  J Gen Microbiol       Date:  1974-01

6.  Studies on the pyocins of Pseudomonas aeruginosa: morphology and mode of action of contractile pyocins.

Authors:  J R Govan
Journal:  J Gen Microbiol       Date:  1974-01

7.  The problem of Pseudomonas cepacia in a hospital.

Authors:  C Randall
Journal:  Can J Public Health       Date:  1980 Mar-Apr

8.  A composite arginine glucose medium for the characterization of Pseudomonas aeruginosa and other gram negative bacilli.

Authors:  D J Stewart
Journal:  J Appl Bacteriol       Date:  1971-12

9.  In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients.

Authors:  M R Moody; V M Young; D M Kenton
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191

10.  Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination.

Authors:  J D Sobel; N Hashman; G Reinherz; D Merzbach
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

View more
  15 in total

1.  Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks.

Authors:  M Okazaki; T Watanabe; K Morita; Y Higurashi; K Araki; N Shukuya; S Baba; N Watanabe; T Egami; N Furuya; M Kanamori; S Shimazaki; H Uchimura
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia.

Authors:  C Lewin; C Doherty; J Govan
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

3.  Discriminant analysis of ribotype profiles of Escherichia coli for differentiating human and nonhuman sources of fecal pollution.

Authors:  S Parveen; K M Portier; K Robinson; L Edmiston; M L Tamplin
Journal:  Appl Environ Microbiol       Date:  1999-07       Impact factor: 4.792

Review 4.  Current status of Pseudomonas cepacia typing systems.

Authors:  C S Rabkin; W R Jarvis; W J Martone
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

5.  The evolution of reduced microbial killing.

Authors:  Jan A C Vriezen; Michael Valliere; Margaret A Riley
Journal:  Genome Biol Evol       Date:  2009-10-20       Impact factor: 3.416

Review 6.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

Review 7.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

8.  Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients.

Authors:  E H Bingen; M Weber; J Derelle; N Brahimi; N Y Lambert-Zechovsky; M Vidailhet; J Navarro; J Elion
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

9.  Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.

Authors:  M L Whiteford; J D Wilkinson; J H McColl; F M Conlon; J R Michie; T J Evans; J Y Paton
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

10.  Ribotype analysis of Pseudomonas pseudomallei isolates.

Authors:  M M Sexton; L A Goebel; A J Godfrey; W Choawagul; N J White; D E Woods
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.